Inventor

WONG KWOK-KIN

US18 patents

⚠️ This page may combine multiple inventors who share the name “WONG KWOK-KIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WONG KWOK-KIN

DANA FARBER CANCER INST INC

Inhibitors of EGFR and methods of use thereof

Combination therapy of transcription inhibitors and kinase inhibitors

Methods of use and pharmaceutical combinations of HDAC inhibitors with BET inhibitors

Microfluidic cell culture of patient-derived tumor cell spheroids

EZH2 inhibitors and uses thereof

Inhibitors of EGFR and methods of use thereof

Compositions and methods of modulating anti-tumor immunity

Compositions and methods for identification, assessment, prevention, and treatment of cancer using NFS1 biomarkers and modulators

Methods for treating cancer

Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors

Methods of diagnosing and prognosing lung cancer

Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response

UNIV NEW YORK

Therapeutic targeting of KMT2D mutant lung squamous cell carcinoma through RTK-RAS signaling inhibition

Combination therapy for treatment of LKB1 deficient cancers

DEPINHO RONALD A

Compositions, kits and methods for identification, assessment, prevention and therapy of cancer

UNIV NORTH CAROLINA CHAPEL HILL

Cyclin dependent kinase inhibitors and methods of use

DIROCCO DEREK P

Protection of renal tissues from ischemia through inhibition of the proliferative kinases CDK4 and CDK6

WONG KWOK-KIN

Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease